Subtype selectivity of a new 1 -adrenoceptor antagonist, JTH-601: comparison with prazosin

By Muramatsu I.   Takita M.   Suzuki F.   Miyamoto S.   Sakamoto S.   Ohmura T.  

European Journal of Pharmacology, Vol. 300, Iss. 1, 1996-04 ,pp. : 155-157

Elsevier

Access to resources Recommend Favorite

In vivo and in vitro pharmacological studies of a new hypotensive compound (QF0301B) in rat: comparison with prazosin, a known 1 -adrenoceptor antagonist

By Orallo F.   Garcia-Ferreiro T.   Enguix M.J.   Tristan H.   Masaguer C.   Ravina E.   Cadavid I.   Loza M.I.  

General Pharmacology, Vol. 40, Iss. 2, 2003-02 ,pp. : 97-108

Elsevier

Access to resources Recommend Favorite

Synthesis and 1 -antagonist activity of derivatives of 4-chloro-5-{4-[2-(2-methoxyphenoxy)-ethyl]-1-piperazinyl}-3(2H)-pyridazinone

By Strappaghetti G.   Barbaro R.   Marucci G.  

European Journal of Medicinal Chemistry, Vol. 35, Iss. 7, 2000-08 ,pp. : 773-779

Elsevier

Access to resources Recommend Favorite

Review on Chemogenomics Approach: Interpreting Antagonist Activity of Secreted Frizzled-Related Protein 1 in Glaucoma Disease with In-Silico Docking

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 16, 2012-08 ,pp. : 1834-1842

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of human ether-a-go-go-related gene potassium channels by α1-adrenoceptor antagonists prazosin, doxazosin, and terazosin

By Thomas Dierk   Wimmer Anna-Britt   Wu Kezhong   Hammerling Bettina   Ficker Eckhard   Kuryshev Yuri   Kiehn Johann   Katus Hugo   Schoels Wolfgang   Karle Christoph  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 5, 2004-05 ,pp. : 462-472

Springer Publishing Company

Access to resources Recommend Favorite